Intuitive Surgical (NASDAQ:ISRG) Trading Up 1.5% – Time to Buy?

Intuitive Surgical, Inc. (NASDAQ:ISRG) shot up 1.5% during mid-day trading on Monday . The company traded as high as $580.47 and last traded at $580.58. 593,514 shares traded hands during trading, a decline of 69% from the average session volume of 1,932,047 shares. The stock had previously closed at $571.88.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Barclays boosted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Price Performance

The firm has a market capitalization of $210.47 billion, a price-to-earnings ratio of 92.18, a PEG ratio of 5.51 and a beta of 1.39. The firm has a 50 day moving average price of $551.99 and a 200-day moving average price of $512.04.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 in the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Institutional Trading of Intuitive Surgical

Large investors have recently made changes to their positions in the stock. SRS Capital Advisors Inc. grew its position in Intuitive Surgical by 15.6% in the fourth quarter. SRS Capital Advisors Inc. now owns 3,208 shares of the medical equipment provider’s stock valued at $1,674,000 after acquiring an additional 432 shares in the last quarter. Asahi Life Asset Management CO. LTD. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $360,000. Clifford Swan Investment Counsel LLC grew its position in shares of Intuitive Surgical by 13.0% during the fourth quarter. Clifford Swan Investment Counsel LLC now owns 1,187 shares of the medical equipment provider’s stock worth $620,000 after buying an additional 137 shares in the last quarter. Norden Group LLC increased its stake in shares of Intuitive Surgical by 8.9% in the fourth quarter. Norden Group LLC now owns 1,746 shares of the medical equipment provider’s stock worth $911,000 after buying an additional 142 shares during the last quarter. Finally, Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical during the 4th quarter valued at $31,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.